Results 221 to 230 of about 12,993 (261)

Extending our confidence in sustained virological response

Liver International, 2016
See Article on Page ...
Maan, Raoel, van der Meer, Adriaan
openaire   +3 more sources

Hepatitis C reinfection after sustained virological response

Journal of Hepatology, 2016
On-going risk behaviour can lead to hepatitis C virus (HCV) reinfection following successful treatment. We aimed to assess the incidence of persistent HCV reinfection in a population of people who inject drugs (PWID) who had achieved sustained virological response (SVR) seven years earlier.In 2004-2006 we conducted a multicentre treatment trial ...
Håvard, Midgard, Benedikte, Bjøro, Arild, Mæland, Zbigniew, Konopski, Hege, Kileng, Jan K, Damås, Jørn, Paulsen, Lars, Heggelund, Per K, Sandvei, Jetmund O, Ringstad, Lars N, Karlsen, Kathrine, Stene-Johansen, John H-O, Pettersson, Dagny H, Dorenberg, Olav, Dalgard   +14 more
openaire   +2 more sources

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon α‐2a and ribavirin

Journal of Gastroenterology and Hepatology, 2007
AbstractBackground and Aim:  The therapeutic effect of pegylated interferon (peg‐IFN)‐α‐2a combination with ribavirin on patients with chronic hepatitis C virus (HCV) infection is dependent on the rapidity of the virological response. The aim of this study was to investigate the predictive value of rapid virological response (RVR) and early virological
Jian-Wu, Yu, Gui-Qiang, Wang, Li-Jie, Sun, Xiao-Guang, Li, Shu-Chen, Li   +4 more
openaire   +2 more sources

Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response

Journal of Gastroenterology and Hepatology, 2010
AbstractBackground and Aim:  A number of hepatitis C virus (HCV) patients without a rapid virological response (RVR) achieved a sustained virological response (SVR) with peginterferon‐α‐2a/ribavirin. The aim of this study was to identify factors associated with SVR in non‐RVR patients.Methods:  Baseline and on‐treatment factors were used to explore the
Chung-Feng, Huang, Jeng-Fu, Yang, Jee-Fu, Huang, Chia-Yen, Dai, Chang-Fu, Chiu, Nai-Jen, Hou, Ming-Yen, Hsieh, Zu-Yau, Lin, Shinn-Cherng, Chen, Ming-Yuh, Hsieh, Liang-Yen, Wang, Wen-Yu, Chang, Wan-Long, Chuang, Ming-Lung, Yu   +13 more
openaire   +2 more sources

S1263 Predictors of Sustained Virological Response Among Patients With Hepatitis C Post OLT and the Impact of Sustained Virological Response on Mortality

Gastroenterology, 2010
G A A b st ra ct s to 4. Prior constitutional symptoms were present in 14%, and 38% were asymptomatic. Acute icteric feature was seen in 47%. Twelve patients had cirrhosis and were transplanted (57%). One had spontaneous remission and 1 died of liver failure.
Matthew J. Moeller, George Divine, Kimberly Ann Brown   +2 more
openaire   +1 more source

Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C

JAMA, 2013
Mr Maisonneuve and Dr Bruno raise the possibility that the association between SVR and reduced occurrence of hepatocellular carcinoma among patients with chronic HCV infection and advanced hepatic fibrosis in our analyses could be confounded by HCV genotype or subtype.
Patrick, Maisonneuve, Savino, Bruno
openaire   +2 more sources

Augmentation of hepatitis C virus‐specific immunity and sustained virologic response

Journal of Viral Hepatitis, 2017
SummaryTreatment for chronic hepatitis C virus (HCV) infection has rapidly evolved into interferon‐free directly acting antiviral regimens (DAA) that result in high sustained virologic response. DAAs primarily work by suppressing HCV replication and rely less on the immune system than interferon‐based therapies.
S. Shrivastava, E. Wilson, B. Poonia, L. Tang, A. Osinusi, A. Kohli, S. Kottilil   +6 more
openaire   +2 more sources

Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment

Journal of Viral Hepatitis
ABSTRACTTo date, the effectiveness of direct‐acting antivirals (DAAs) discontinued before 4 weeks has not been analysed in routine clinical practice. The study aimed to determine whether such a short therapy will enable achieving a sustained virological response under real‐world experience.
Robert Flisiak, Dorota Zarębska‐Michaluk, Ewa Janczewska, Anna Parfieniuk‐Kowerda, Włodzimierz Mazur, Marek Sitko, Justyna Janocha‐Litwin, Rafał Krygier, Beata Lorenc, Anna Piekarska, Barbara Sobala‐Szczygieł, Krystyna Dobrowolska, Łukasz Socha, Jerzy Jaroszewicz   +13 more
openaire   +3 more sources

Telaprevir: Looking for a sustained virologic response in hepatitis C virus infection

Drugs of Today, 2011
Telaprevir, a hepatitis C virus (HCV) NS3/NS4A protease inhibitor, was recently approved by the U.S. Food and Drug Administration for the treatment of chronic HCV genotype 1 infection. When given in combination with pegylated interferon and ribavirin, it demonstrated improved efficacy over conventional pegylated interferon and ribavirin therapy ...
V, Nehra, S A, Rizza, R, Talwani, Z, Temesgen   +3 more
openaire   +2 more sources

The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C

Journal of Viral Hepatitis, 2010
Summary.  Previous reports suggest cryoglobulinemia might influence the hepatitis C virus (HCV) infection clinical course and treatment response but this association has not been thoroughly evaluated. We aimed to assess the relationship between cryoglobulinemia and sustained viral response (SVR) in patients treated for HCV infection.
A G, Vigani, A, Macedo de Oliveira, R, Tozzo, M H P, Pavan, E S, Gonçales, V, Fais, N S, Gonçales, F L, Gonçales   +7 more
openaire   +2 more sources